123 related articles for article (PubMed ID: 18470760)
1. Testing for positive control activity in a thorough QTc study.
Zhang J
J Biopharm Stat; 2008; 18(3):517-28. PubMed ID: 18470760
[TBL] [Abstract][Full Text] [Related]
2. Validation testing in thorough QT/QTc clinical trials.
Tsong Y; Zhong J; Chen WJ
J Biopharm Stat; 2008; 18(3):529-41. PubMed ID: 18470761
[TBL] [Abstract][Full Text] [Related]
3. Statistical issues of QT prolongation assessment based on linear concentration modeling.
Tsong Y; Shen M; Zhong J; Zhang J
J Biopharm Stat; 2008; 18(3):564-84. PubMed ID: 18470764
[TBL] [Abstract][Full Text] [Related]
4. Statistical issues including design and sample size calculation in thorough QT/QTc studies.
Zhang J; Machado SG
J Biopharm Stat; 2008; 18(3):451-67. PubMed ID: 18470755
[TBL] [Abstract][Full Text] [Related]
5. Statistical assessment of QT/QTc prolongation based on maximum of correlated normal random variables.
Cheng B; Chow SC; Burt D; Cosmatos D
J Biopharm Stat; 2008; 18(3):494-501. PubMed ID: 18470758
[TBL] [Abstract][Full Text] [Related]
6. Effect of baseline measurement on the change from baseline in QTc intervals.
Tian H; Natarajan J
J Biopharm Stat; 2008; 18(3):542-52. PubMed ID: 18470762
[TBL] [Abstract][Full Text] [Related]
7. Sample size, power calculations, and their implications for the cost of thorough studies of drug induced QT interval prolongation.
Malik M; Hnatkova K; Batchvarov V; Gang Y; Smetana P; Camm AJ
Pacing Clin Electrophysiol; 2004 Dec; 27(12):1659-69. PubMed ID: 15613131
[TBL] [Abstract][Full Text] [Related]
8. Multiple comparisons of repeatedly measured response: issues of validation testing in thorough QT/QTc clinical trials.
Tsong Y; Yan LK; Zhong J; Nie L; Zhang J
J Biopharm Stat; 2010 May; 20(3):654-64. PubMed ID: 20358443
[TBL] [Abstract][Full Text] [Related]
9. Sample size calculations in thorough QT studies.
Zhang L; Dmitrienko A; Luta G
J Biopharm Stat; 2008; 18(3):468-82. PubMed ID: 18470756
[TBL] [Abstract][Full Text] [Related]
10. Multiple comparisons of repeated measured response: issues of assessment of prolongation of QT interval in thorough QT trials.
Tsong Y; Zhong J
J Biopharm Stat; 2010 May; 20(3):604-14. PubMed ID: 20358439
[TBL] [Abstract][Full Text] [Related]
11. QT/QTc prolongation in placebo-treated subjects: a PhRMA collaborative data analysis.
Agin MA; Aronstein WS; Ferber G; Geraldes MC; Locke C; Sager P
J Biopharm Stat; 2008; 18(3):408-26. PubMed ID: 18470753
[TBL] [Abstract][Full Text] [Related]
12. Impact of baseline ECG collection on the planning, analysis and interpretation of 'thorough' QT trials.
Sethuraman V; Sun Q
Pharm Stat; 2009; 8(2):113-24. PubMed ID: 18481273
[TBL] [Abstract][Full Text] [Related]
13. Statistical analysis methods for QT/QTc prolongation.
Ma H; Smith B; Dmitrienko A
J Biopharm Stat; 2008; 18(3):553-63. PubMed ID: 18470763
[TBL] [Abstract][Full Text] [Related]
14. A statistical assessment of QT data following placebo and moxifloxacin dosing in thorough QT studies.
Stylianou A; Roger J; Stephens K
J Biopharm Stat; 2008; 18(3):502-16. PubMed ID: 18470759
[TBL] [Abstract][Full Text] [Related]
15. Assay sensitivity in "Hybrid thorough QT/QTc (TQT)" study.
Huang DP; Chen J; Dang Q; Tsong Y
J Biopharm Stat; 2019; 29(2):378-384. PubMed ID: 30346877
[TBL] [Abstract][Full Text] [Related]
16. Guest editors' notes on statistical issues in design and analysis of thorough QTc studies.
Tsong Y; Zhang J
J Biopharm Stat; 2008; 18(3):405-7. PubMed ID: 18470752
[No Abstract] [Full Text] [Related]
17. Performance characteristics for some typical QT study designs under the ICH E-14 guidance.
Hutmacher MM; Chapel S; Agin MA; Fleishaker JC; Lalonde RL
J Clin Pharmacol; 2008 Feb; 48(2):215-24. PubMed ID: 18199896
[TBL] [Abstract][Full Text] [Related]
18. Use of ANOVA to estimate inter- and intra-reader variability for a group of readers in thorough QT/QTc studies.
Natekar M; Mahajan V; Satra A; O'Kelly M; Karnad DR
Clin Pharmacol Ther; 2008 Mar; 83(3):489-91. PubMed ID: 18183035
[TBL] [Abstract][Full Text] [Related]
19. On power and sample size calculation for QT studies with recording replicates at given time point.
Chow SC; Cheng B; Cosmatos D
J Biopharm Stat; 2008; 18(3):483-93. PubMed ID: 18470757
[TBL] [Abstract][Full Text] [Related]
20. Literature review and pilot studies of the effect of QT correction formulas on reported beta2-agonist-induced QTc prolongation.
Milic M; Bao X; Rizos D; Liu F; Ziegler MG
Clin Ther; 2006 Apr; 28(4):582-90. PubMed ID: 16750469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
